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Introduction: Causation and conceptual change via cervical cancer  
   
In this paper, I offer one example of conceptual change. Specifically, I contend that the discovery that viruses could 
cause cancer represents an excellent example of branch jumping, one of Thagard’s1 nine forms of conceptual change. 
Prior to about 1960, cancer was generally regarded as a degenerative, chronic, non-infectious disease. Cancer 
causation was therefore usually held to be a gradual process of accumulating cellular damage, caused by relatively 
non-specific component causes, acting over long periods of time. Viral infections, on the other hand, were generally 
understood to be acute processes, whereby single, specific and necessary causal agents acted alone to produce 
disease. However, during the 1960s and 1970s, a number of cancers were discovered to have an infectious aetiology. 
Of particular note were two—Burkitt’s lymphoma and cervical cancer—which I will discuss in detail later in this piece. 
Together, these discoveries led, in the short term, to a tentative aetiological reclassification of some types of cancer 
as infectious diseases and, in the longer term, to a full-blown reclassification of cancer as an aetiological disease 
branch in its own right. This process of reclassification forms the empirical basis for my concluding remarks on the 
influence of classification upon causation in medicine. Through this, I aim to demonstrate that conceptual change, far 
from being a purely abstract concern of the philosopher of science, is of substantial import to scientific practitioners. 
 
 
Burkitt’s lymphoma (BL) 
 
BL is an extranodal B-cell lymphoma2 which occurs primarily in young children living in sub-Saharan Africa. It was first 
described in 1958 by Denis Burkitt in the following way. First, while malignant tumours of the jaw are generally rare in 
children, they appeared to be unusually common in parts of Uganda. In fact, they were by far the commonest 
malignant disease of childhood.3 These jaw tumours appeared to be part of a wider clinical syndrome, with 
histologically similar material also found in other anatomical sites, including within the abdomen. This syndrome was 
strikingly unusual in three respects. First, despite the high incidence of the disease in Uganda, it was unknown in 
other parts of the world, suggesting the existence of some particular geographical distribution. Second, the disease 
appeared to affect only young children, in sharp contrast to most tumours. Third, the disease affected several sites of 
the body simultaneously, including multiple sites within the jaw and within the abdomen. For this pathogenic 
mechanism to be the case, a novel process of either simultaneous, multifocal oncogenesis occuring in both jaw and 
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abdomen, or a mechanism of sudden metastasis by unknown means, would be required. Together, these three 
anomalies suggested the action of an unusual causal mechanism underlying the disease. 
 
The initial research direction was this. First, the clinical picture was developed through the investigation of further 
instances of the disease. While this led to numerous minor refinements, no substantial developments in 
understanding the aetiology of the disease were made. Second, the epidemiology of the tumour was systematically 
investigated. Importantly, the geographical limits of the disease were sought by conducted a postal survey of African 
hospitals, asking for sightings of the distinctive clinical features of the lymphoma.4 This survey was sufficiently 
successful to allow the mapping of tumour cases across large parts of Africa. As a consequence of this mapping 
exercise, the lymphoma syndrome was seen to occur in a belt across the continent, spanning the equator, with a tail 
running down the east coast and sparing the northern and southern extremities.5 The islands of Zanzibar and Pemba, 
lying off the coast of Tanganyika (now incorporated into Tanzania) were spared entirely. Furthermore, there 
appeared to be areas within this ‘lymphoma belt’ in which the tumour did not occur or, at least, occurred with greatly 
reduced frequency. This distribution led to enquiries into the unifying factors common to the regions of high tumour 
incidence. It was noted that this distribution could be mirrored by the consideration of certain climatic factors. For 
instance, eliminating all areas where the mean temperature fell below 15°C at any time of year, over 1500m altitude, 
and where mean annual rainfall was less than 750mm, gave a map which was “almost identical with the map of 
tumour distribution”.6 
 
This geographic distribution suggested the activity of some causally significant entity which depended on climatic 
factors, for instance flora or fauna. Two arthropods of known medical importance had distributions similar to that of 
BL. The first was the tsetse fly (Glossina spp.), the insect vector of African trypanosomiasis, while the second was the 
Anopheles mosquito, the vector of malaria. Certain recent outbreaks of viral disease in the region, in turn, suggested 
that these insects might act as vectors for unknown viruses. Could an insect-vectored virus be the cause of BL? 
 
While the viral hypothesis was initially strengthened by the presence, under electron microscopy, of changes 
suggestive of viral activity in BL tumour cells, no virus itself was detectable, although a wide range of techniques were 
used, including  cell cultures, infection of fertilized hens eggs and inoculation of material into newborn mice.7 When 
the cells of BL were grown in cell culture, however, a different story developed. On the 24th of Feb 1964, samples of 
the first cell line derived from BL were examined using thin section electron microscopy. The findings were exciting–
with “...unequivocal virus particles in a cultured BL cell in the very first grid square to be searched”. These virus-like 
particles were subsequently rapidly detected in other BL cell lines.8 
 
These virus-like particles seen on electron microscopy was the first detection of a new herpesvirus, which later 
became known as the Epstein-Barr virus (EBV) after its discoverers.9 Immunofluorescence testing revealed that viral 
antigens were immunologically reactive against the serum of patients with Burkitt’s lymphoma, and against BL cells. 
As might be expected, the extent of immunofluorescence correlated with virus particles as seen using electron 
microscopy.10 Mystifyingly, though, despite the relatively specific immunological response obtained in cases of BL, it 
was also immunologically reactive against the sera of non-BL individuals, including leukaemia patients,11 individuals 
with nasopharyngeal carcinomas12 and, most confusingly of all, against many normal North American control 
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individuals.13 This suggested that infections with EBV were far more common in non-BL populations than might be 
expected if EBV were really the causal agent of BL.  
 
So if EBV was to be the cause of BL, an explanation for its presence in so many individuals without the disease was 
required. Could it be the case that, while EBV caused BL, it also caused a range of other diseases? Perhaps the most 
significant development in this field arose as following. While conducting a series of surveys for EBV antibodies using 
sera from a variety of paediatric illnesses of unknown, but presumptively viral, aetiology, one researcher by chance 
developed Infectious Mononucleosis (IM; glandular fever). It was discovered that, following this infection, her 
leukocytes became capable of growing in cell culture, a property they had not possessed when tested before the 
development of the disease. While she initially did not display antibodies to EBV, from the outset her cultured cells 
expressed EBV antigens, and contained the chromosomal abnormalities characteristic of BL.14 When further sera from 
IM patients were examined, they were all found to be strongly positive for anti-EBV antibodies. This led to the 
conclusion that IM was causally related to EBV: 
 
“Patients with infectious mononucleosis regularly develop antibodies to the herpes-type virus (EBV) 
found in cultures derived from Burkitt’s tumors or other cells of the hematopoietic system. . . The 
epidemiology of IM and the seroepidemiology of EBV share many features. Thus, it appears that EBV, 
or a close relative of it, is the cause of IM. This conclusion does not preclude the possibility that EBV 
might also be involved, either directly or indirectly, in the etiology of Burkitt’s lymphoma.”15 
 
This probable aetiologic relationship could therefore explain the serological evidence of past EBV infection in 
otherwise healthy individuals. However, the causal mechanism linking BL and EBV was still rather incomplete  by the 
early 1970s. There was, therefore, much resistance to it until the completion of various epidemiological studies 
demonstrating the increased risk of BL in populations with high levels of anti-EBV antibodies. One important example 
of these types of investigation was the large prospective seroepidemiological study in the lymphoma belt16 that 
began in 1971. It followed 42 000 children from birth to 8 years old in the West Nile District of Uganda. Serum 
samples were taken at enrollment, and enrolled children were then monitored for the development of BL. In total, 14 
of the 42 000 participants developed the disease during the lifetime of the trial. It was show that affected individuals 
had higher levels of anti-EBV antibodies than controls at baseline. When this finding was combined with earlier work 
that populations at high BL risk tended to acquire anti-EBV antibodies at a younger age than individuals in 
populations at low risk,17  a mechanism of differential pathogenesis began to be developed. In broad terms, 
individuals who became infected with EBV young were at risk of developing BL,18 while individuals becoming infected 
later in life tended to develop IM. 
 
So BL is one example of human viral oncogensis that contributed significantly to the conceptual change occuring in 
cancer causation. The causal arguments above show modifications to, not only arguments regarding cancer 
causation, but also to those regarding the causation of viral illnesses more widely. However, the generalizability of 
these modifications appears doubtful. For one, Burkitt’s lymphoma is a rather atypical tumour in several respects. It is 
rather uncommon, and occurs in a particular distribution – both geographically, restricted to a narrow band of sub-
Saharan Africa, and in a narrow range of susceptible ages – really only between 5 and 8 years. For another, the causal 
relationship between EBV and its range of clinical manifestations remains highly complex. In detail, it is not at all clear 
what other factors predispose towards the different manifestations of the same virus in different populations. The 
case of BL and EBV therefore presented something akin to an oddity, rather than a revolution in cancer causation.  It 
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would take the discovery of viral oncogensis in a much more common setting before this conceptual change really 
took hold. 
 
 
Cervical cancer 
 
A much more surprising candidate for viral oncogenesis was cervical cancer. Unlike Burkitt’s lymphoma, cervical 
cancer is a much more typical tumour: it occurs relatively commonly, has a worldwide distribution and (generally) 
increases in incidence with age. Before about 1960, cervical cancer was believed to have similar risk factors to other 
malignant diseases.  
 
“Long-continued irritation and chronic inflammation are probably the conditions which pave the way 
for the development of the new growth.”19 
 
These risk factors were thought typical for a disease of the degenerative-chronic type. However, it later emerged that 
the risk factors for cervical cancer were similar to those of an infectious disease.  For instance, as one of the major 
reviews20 of the epidemiology and aetiology of cervical cancer rather bluntly put it: 
 
“The cancer patient is characterised by more marital misadventures, divorce and separation, more 
pre-marital coitus and deliveries and more sexual partners.”21 
 
A great deal of sound epidemiologic data appeared to support this thesis, with a complex web of socioeconomic 
factors, particularly those indicating social class, marital and sexual habits and features of male sexual partners, 
modifying the risk of developing the disease.22  However, no specific mechanism was developed to explain these 
phenomena. Instead, background plausibility assumptions played the major role in deciding which factors were 
causal, and which were confounders—that is, which factors were merely correlated markers of genuinely causal ones. 
So for instance, while investigating the correlation between marriage and the development of cervical cancer, 
Lombard and Potter noted that a direct causal link was implausible:  
   
“...no one would consider the mere ceremony of marriage to have a bearing on the causation of the 
disease”23  
   
That is not to say there was no relevant investigation of the mechanism of oncogenesis. Some research—particularly 
into the mechanism of male factors in cervical cancer24—attempted to investigate questions raised by 
epidemiological research. But in general, epidemiological research was not coupled to a corresponding laboratory 
program of the mechanism of cancer causation.  
   
That is until the discovery of human viral oncogenesis. A viral infection causing cervical cancer could provide a means 
of unifying and explaining these risk factors, and, by about 1970, cervical cancer commonly believed to be caused by 
a virus. The formerly known social factors were now generally explained as acting by modifying the chances of a 
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woman contracting it. Interestingly, though, this emergent research program was not a result of finding the correct 
causal virus. We now know that cervical cancer is caused by infection with certain strains of the human 
papillomavirus (HPV). However, this was not known until the 1980s. In fact, much of this earlier research suggested 
that herpes simplex virus (HSV), responsible for, amongst other things genital herpes infections, was responsible.25 
This seemed highly plausible: herpes viruses were known to be capable of causing cancers—for instance, the causal 
virus of Burkitt’s lymphoma is a type of herpes virus; the epidemiology of the virus was consistent with the existing 
evidence and herpes infections and cervical cancer were rather well correlated on an individual case basis.  In fact, 
the evidence linking HSV and cervical cancer was rather impressive.  
 
To give a summary of this evidence,26 HSV is a commensal organism, likely to grow in the female reproductive tract. In 
fact, it was known to be responsible for genital herpes infections. Thus, it was also known to be transmitted through 
sexual intercourse, offering a possible explanation for some cervical cancer risk factors. These included the role of 
first coitus, marriage or pregnancy, at an early age, the role of multiple sexual partners or promiscuity in increasing 
disease incidence, and the finding that women of low socioeconomic status were at higher risk of cervical cancer than 
wealthy. Second, herpesviruses were known to be implicated in other malignant diseases. Not only was the causal 
agent of BL a herpesvirus, but many non-human animals were known to suffer from herpes-associated malignant 
diseases. Third, there was an apparent serological association between the virus and the cancer. Antibodies against 
one type of HSV (HSV2)  were present in prostitutes (who have a very high rate of cervical cancer) more than twice as 
often as in control populations and four times as often in women with cervical cancer than controls.27 Fourth, HSV 
was known to be capable of causing chromosomal abnormalities in vitro in both animal and human cells,28 similar to 
those known to be associated with many sorts of cancer. Fifth, it also became apparent that fragments of HSV DNA 
could be directly detected in cervical cancer cell, suggesting some specific role in pathogenesis.29  
 
These supporting pieces of evidence were highly plausible, but did not constitute a causal mechanism for cervical 
cancer. Attempts to produce an experimental model of disease in animals were problematic. Early experimental 
attempts to induce tumours in animals by inoculation with various herpes simplex strains failed outright.30 Later 
animal inoculation experiments too were equivocal, although some of them displayed a slight apparent effect of 
HSV2 inoculation on tumour development. In both cases this work was complicated by the very high subject mortality 
caused by the lytic effects of HSV. I might also speculate that a general unwillingness to publish negative findings 
makes it likely that there were even more unsuccessful attempts to induce cervical tumours using HSV than the 
literature reveals. 
 
Similar experiments using in vitro cell cultures were more successful. For instance, cells in vitro could be transformed 
by incubation with UV-inactivated HSV2. These transformed cells displayed HSV antigens,31 and were capable of 
inducing malignant tumour formation when inoculated into animal subjects. Fragments of HSV nucleic acids were 
also detectable in these cell lines.32 
 
Thus the general oncogenic properties of the herpesviruses revealed, in part, by these experiments required some 
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specific demonstration in cervical cancer. However, no publications reporting such findings seem to be extant. It thus 
was the role of epidemiology to suggest that the herpesvirus hypothesis was mistaken. As with Burkitt’s lymphoma, a 
large prospective seroepidemiological study was undertaken. This involved more that 10 000 women in Prague. While 
the results of this study showed general agreement between cervical cancer risk and the previously known risk 
factors,33 no differences in HSV2 status appeared to exist between matched control subjects and cancer cases.34 Thus 
this study did not seem to support a causal role for HSV in the development of the cancer. Thus, the role of HSV as a 
specific, necessary cause of cervical cancer seemed untenable. Instead, HSV was now thought to correlate with a 
second sexually transmitted agent. Various candidate agents were investigated, including human papillomavirus 
(HPV). 
 
HPV initially seemed a most unpromising agent, for the simple reason that no detection of the virus had been made 
in cervical cancer tissue. However, it did seem at least plausible that HPV could have a pathogenic role. For example, 
various other diseases–including skin warts and the rare, heritable skin disease epidermodysplasia verruciformis–
were known to be related to papillomavirus infection. Electron microscopy of material derived from several types of 
wart revealed strong morphological similarities between the various virus particles.35 Similar too was the clinical 
course of disease seen during experimental or accidental wart transmission experiments. Together, these two 
features suggested that papillomaviruses could cause both benign and malignant diseases, and were transmissible. 
Yet the means by which this transmission could occur was unknown. For one, the different known papillomaviruses, 
despite having similar gross morphologies and genome lengths,36 were antigenically distinct and their genomes 
showed a good deal of variance when analysed in terms of base composition.37 Both immuno-EM and RNA-
hybridisation experiments revealed a significant degree of difference between the papillomaviruses associated with 
different disease, with material derived from one type of disease appearing to share neither immunological nor 
genetic characteristics with material derived from others.38 There were important epidemiological questions too. 
Different papillomavirus diseases in humans (warts, genital warts or laryngeal warts) characteristically occurred at 
different ages and in different populations. This finding too seemed to count against a strongly unified cause for these 
diseases. 
 
Were HPV a group of related viruses? Could this explain the different clinical and experimental properties of the 
(visually identical) viruses? Part of the puzzle was resolved when researchers examined in detail the genomes of 
papillomaviruses from different types of wart material, when it rapidly became apparent that a number of diverse 
HPV strains were present. These strains were immunologically distinct, suggesting that, despite the previous lack of 
detection of the virus in cervical cancer cells, HPV could still be causally implicated: 
 
“The condyloma agent has been entirely neglected thus far in all epidemiological and serological 
studies relating . . . to cervical . . . carcinomas. This is particularly unusual in view of the localization of 
genital warts, their mode of venereal transmission, the number of reports on malignant transition, 
and the presence of an agent belonging to a well-characterized group of oncogenic DNA viruses.”39 
 
So the discovery that HPV did, in fact, cause cervical cancer required the development of a large number of strain-
specific tests for HPV. In fact, it was not until the discovery and cloning of HPV–16 from a cervical cancer tissue 
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sample that HPV could be detected in most cases of cervical cancer.40 This newly discovered strain of HPV was highly 
specific for cervical cancer, and generally could not be detected in other papillomavirus-related disease. A degree of 
strain variation by geographical region also seemed to be the case, with HPV-16 being detectable in at much higher 
rates in European cervical cancer samples than those from Africa or South America. A second novel strain, HPV–18, 
was soon detected in an African cervical cancer sample by similar means to that of HPV–16,41 which also seemed 
relatively region-specific. Taken together, HPV–16 and –18 were present in most tested cervical cancer samples. This 
demonstration of strain-specificity was further support for the causal role of the virus. Unlike the earlier causal 
candidate HSV, a pathogenic mechanism was rapidly developed linking the virus with the disease. While I won’t 
attempt a detailed review of it here, it seems worth giving an outline of a few of the major developments. First, it was 
found that cloned HPV DNA alone was capable of transforming cells in vitro.42 This process of transformation involved 
incorporation of the HPV genome into the host genome.43 RNA analysis revealed the expression of a number of non-
structural viral proteins in these immortalised cells. These ‘early’ viral proteins appeared causally important in cellular 
transformation.44 In particular, the E6 and E7 proteins appeared to be responsible for modifying cell cycle regulation 
through a number of specific mechanisms. Acting together, HPV–18 E6 and E7 proteins were found to be necessary 
and sufficient for cell transformation, in vitro, at least.45 E6 is necessarily responsible for the maintenance of 
tumours.46 However, acting alone, it also appeared capable of inducing immortalisation in some cell-types, causing 
cell-cycle deregulation by p53 degradation.47 E7, though, acts through interactions with the retinoblastoma gene 
product pRp, leading to cell-cycle deregulation via disruption of the actions of transcription factor E2F.48 Thus, E7 acts 
as the initiator of cell immortalization.49 This process of HPV integration, early protein expression and disruption of 
cell-cycle regulation was suggested as the mechanism underlying the transformation of cells. These immortalised cells 
appeared capable too of malignant progression. In vitro studies of keratinocytes immortalised by HPV became 
malignant in a stochastic fashion upon prolonged passage.50 
 
In summary, following prolonged investigation of HPV, particularly focusing on the technical difficulties of detecting 
the virus or growing it in culture, a strong statistical-mechanical link with cervical cancer was uncovered, with 
epidemiological investigations playing a subordinate role.51  It is now thought that the evidence linking HSV and 
cancer of the uterine cervix can be explained on the grounds of similarity of risk factors: behaviours which place the 
individual at high risk for contracting HPV also place them at high risk of contracting HSV. 
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Causal classification and conceptual change 
 
At the outset of this piece I suggested that the discovery of the viral oncogenesis led to a revisionary, branch-jumping 
reclassification of cancer aetiology in general. While I hope I have demonstrated how this came about, what is the 
significance of such a reclassification? In order to answer this question, I need to discuss the ways by which disease 
are classified in clinical practice.  
 
For instance, when making a diagnosis, the clinician may use classifications in order to understand the nature and 
cause of symptoms. Two sorts of classification are particularly important for physical illnesses. One way of classifying 
a disease process would be to begin by dividing possible causes of disease by their relevant anatomical site. To give 
an example, the symptom “pain in the abdomen” may arise as a result of disease occuring in a number of sites. These 
include:52 
 
1. The stomach or duodenum (for instance, a perforated gastric or duodenal ulcer, perforated gastric carcinoma 
or acute gastritis) 
2. The intestines (small bowel obstruction, Crohn’s disease, intussusception) 
3. The appendix (acute appendicitis) 
4. The pancreas (acute pancreatitis, pancreatic trauma) 
5. The gallbladder or bile-ducts (gall stone, acute cholecystitis, acute cholangitis) 
6. The liver (trauma, acute hepatitis, malignancy, congestive heart failure); or 
7. The spleen (trauma, spontaneous rupture, infarction) 
 
and so on. But we could also classify these diseases in a second way, by their aetiology.53 So the same symptom might 
be caused by: 
 
1. Vascular diseases (congestive heart failure causing hepatic engorgement, splenic infarction...) 
2. Infections (acute hepatitis, spontaneous splenic rupture54) 
3. Cancer (perforated gastric carcinoma, small bowel obstruction, hepatic malignancy) 
4. Trauma (pancreatic trauma, hepatic trauma, splenic trauma) 
5. Autoimmune diseases (Crohn’s disease) 
6. Metabolic diseases (gall stone) 
7. Endocrine diseases 
8. Degenerative diseases 
9. Iatrogenic and idiopathic diseases 
10. Congenital diseases 
 
These causal classifications are useful, in a relatively superficial sense, for understanding patterns of disease. As an 
example, if we classify a set of diseases anatomically it may be difficult to detect their underlying aetiology. So while 
an individual might have symptoms compatible with pain arising in the pancreas, liver and spleen, an anatomical 
classification merely suggests an appropriate group of sites suitable for further investigation. If we were to attempt 
an aetiological classification, on the other hand, the same individual might be seen to have suffered trauma to the 
pancreas, liver and spleen, suggesting a coherent mechanism underlying all of their ailments. While in such a simple 
case any cognitive gain seems trivial, in more complex disease process aetiological classifications are likely to be 
rather more helpful. Take the case of an individual with an enlarged thryroid gland, an irregular heart rhythm (an 
arrhythmia) and acute abdominal pain. Here, an aetiological classification is likely to suggest an underlying 
mechanism in a way that an anatomical classification will not. In this instance, one possible explanation for these 
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symptoms could be as follows. First, the enlarged thyroid gland could indicate that the patient is suffering from 
Graves’ disease. One consequence of this is a predisposition towards atrial fibrillation, a type of cardiac arrhythmia. A 
consequence of this atrial fibrillation is an increased risk of unwanted blood clots. One of these clots may have caused 
a splenic infarction, leading to the abdominal pain. In this case, an anatomical classification will have been unhelpful 
in discovering this causal mechanism. Importantly for practice, discovering this underlying disease mechanism 
suggests therapeutic strategies in a manner that anatomical classification does not.  
 
There is a more fundamental sense in which reclassifications are important. The further discovery of viral causes of 
cancer, such as has recently happened in the case of Merkel cell carcinoma,55 or the discovery of new treatments for 
existing cancers requires the exploitation of causes in such a way as to be impossible in the absence of a correct 
classification. It would have been inconceivable for this to have occurred if the discovery of viral oncogenesis had 
constituted a conceptual change taking the form of simple addition to cancer as it existed within the degenerative 
disease hierarchy. These causal arguments would remain unintelligible without acceptance of such revisions in 
conceptual structure. In part, the reasons for the acceptance of this reclassification relate to the improvements 
offered in terms of causal explanatory coherence. Maximising coherence involves retaining much evidence that was 
developed at earlier stages of understanding cancer causation. For example, in order to maintain explanatory 
coherence, we should seek to retain the finding that cervical cancer incidence varies by number of sexual partners. 
This has occurred by fitting this observation into the broader framework of causation by HPV. Now promiscuity does 
not cause cervical cancer. Instead, it increases the risk of contracting HPV. Thus the discovery of viral oncogenesis 
does not involve replacing all that had been known about cancers. Rather, it was in part a matter of fitting existing 
evidence in to a new causal archetype.  
 
This is reflected in the sorts of tools for causal inference applied to the case. For instance, within the paradigm of 
infectious disease, there were already well-used tools for interpreting epidemiologic and laboratory data, such as the 
Koch-Henle postulates56 which could be used to interpret existing data when making new causal claims. So when an 
infectious cause was suspected for cervical cancer, researchers began to use tools originating in infectious disease 
research, such as seroepidemiological surveys, electron microscopy and animal transfection experiements in their 
search for causes. This—ideally—allowed the interpretation of risk factors and other pieces of causal knowledge 
identified at an earlier stage of cancer classification. Thus the risk of developing the disease under certain conditions 
of marital status, sexual habits, social class and so on were examined in terms of a particular underlying causes, 
namely a virus. While it was the discovery of viral oncogenesis that finally made the case for cancer reclassification, it 
was the suspicion that a conceptual reclassification could be made that allowed these questions to be formulated in 
the first instance. 
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